Skip Main Navigation
Page Content

Save This Event

Event Saved

Investor Spotlight: Novartis Venture Fund

JLABS @ Toronto

Tuesday, April 3, 2018 from 10:30 AM to 1:00 PM (EDT)

Investor Spotlight: Novartis Venture Fund

Ticket Information

Ticket Type Sales End Price * Fee Quantity
Presentation & Lunch   more info Apr 2, 2018 CA$15.00 CA$1.90
Media/Press   more info Mar 27, 2018 Free CA$0.00
Volunteer   more info Mar 27, 2018 Free CA$0.00
* Prices include GST/HST

Share Investor Spotlight: Novartis Venture Fund

Event Details

Let's get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC's, Angels and other investment entities.

On April 3rd, Dr. Aaron Nelson, Principal at Novartis Venture Fund will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due March 15, 2018. Apply Here.

Program Overview:
Novartis Venture Fund (NVF) primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program.

They invest in North America, Europe, Israel and Asia/Pacific with approximately USD 800 million under management in committed capital and more than 40 portfolio companies. Novartis Venture Fund continues their strategy of making larger focused investments and anticipate total investments up to USD 30 million per company over its life.

NVF makes equity investments in life sciences at all stages companies across:

  • Biotechnology/Biopharma
  • Medical Devices
  • Diagnostics

NVF typically leads or co-leads an investment and plays an active role on company boards.

Following the presentation, don't miss this opportunity to introduce yourself to Aaron during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Novartis Venture Fund will provide an intimate forum to discuss your company.

10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking and Lunch
12:30 PM - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on March 15th, 2018.

$15 | General Public
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on April 2nd (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must apply for a one-on-one meeting ahead of time. The one-on-one application period ends on March 15.

JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Novartis Venture Fund Representative:
Dr. Aaron Nelson | Principal, Novartis Venture Fund
Dr. Aaron Nelson is a Principal in Cambridge, MA, USA. Prior to joining NVF, he was an investor at dRx Capital, the joint investment company of Novartis and Qualcomm, focused on Digital Medicine. dRx catalyzes the success of digital medicine products, services, and business models by investing in early-stage companies and leveraging networks in Pharma, Mobile/IT, and the investment community. Previously, Aaron worked on technology strategy across multiple Business Units within Novartis, including Strategic Project Leader for the Trials of The Future program and Group Head in the Investigative Toxicology organization. Aaron studied medicine at Tufts University, cell and microbiology at the University of Pennsylvania and the Karolinska Institutet, and completed his undergraduate studies at Cornell University.
Connect with Aaron:   Connect on LinkedIn

Have questions about Investor Spotlight: Novartis Venture Fund? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where

JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1

Tuesday, April 3, 2018 from 10:30 AM to 1:00 PM (EDT)

  Add to my calendar


JLABS @ Toronto

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit

  Contact the Organizer
Investor Spotlight: Novartis Venture Fund
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.